A CLINICAL CASE OF DELIVERY OF A PATIENT WITH HEREDITARY ANGIOEDEMA
Main Article Content
Abstract
The article presents a clinical case of delivery of a patient with orphan disease - hereditary angioedema. The complexity of managing a patient with this pathology is demonstrated.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Federal clinical guidelines for the diagnosis and treatment of patients with hereditary angioedema (HAO). Russian Association of Allergologists and Clinical Immunologists. Moscow, 2014. Russian (Федеральные клинические рекомендации по диагностике и лечению больных с наследственным ангиоотеком (НАО). Российская ассоциация аллергологов и клинических иммунологов. М., 2014)
Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012; 67(2): 147-157
Riedl M. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012; 34(3): 623-630
Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014; 69(5): 602-616. doi: 10.1111/all.12380
Zuraw BL, Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol. 2000; 105(3): 541-546. doi: 10.1067/mai.2000.104780
Bowen B, Hawk JJ, Sibunka S, Hovick S, Weiler JM. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol. 2001; 98(2): 157-163. doi: 10.1006/clim.2000.4947
Bork K. Hereditary angioedema with normal C1 inhibitor. Immunol Allergy Clin North Am. 2013; 33(4): 457-470. doi: 10.1016/j.iac.2013.07.002
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006; 119(3): 267-274. doi: 10.1016/j.amjmed.2005.09.064
Latysheva TV, Latysheva EA, Manto IA. Short-term prophylaxis of manifestations of hereditary angioedema. Russian Medical Journal. 2018; 8: 35-58. Russian (Латышева Т.В., Латышева Е.А., Манто И.А. Краткосрочная профилактика проявлений наследственного ангионевротического отека //Российский Медицинский Журнал. 2018. № 8. С. 53-58)
Farkas H, Harmat G, Kaposi PN, Karádi I, Fekete B, Füst G, et al. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol. 2001; 13(10): 1225-1230. doi: 10.1097/00042737-200110000-00016
Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006; 101(3): 619-627. doi: 10.1111/j.1572-0241.2006.00492.x